top of page
Copharix Pharma Analytics provide insights concerning factors that affect net consumer prices and market dynamics for pharmaceutical products.
Copharix Insurer Analytics enable better characterization of healthcare risks and provide optimization algorithms to mitigate risks.
Copharix Analytics provide insights that power informed decisions!
Develops and provides healthcare analytics, informatics and information services and solutions that utilize large databases of healthcare transactional and clinical data;
Works in close collaboration with various participants in the healthcare delivery value chain to address their needs for business intelligence insights to support strategic corporate decision making such as pricing, coupon discount programs, and salesforce optimization;
Provides innovative healthcare analytics, informatics and information services that are designed to enable more accurate assessments of the impact of corporate decisions and to facilitate processes for improving the quality of such decisions; and
Invents innovative methodologies which are embodied in patented software to leverage healthcare market generated data and provide indexes of prices and performance.
Copharix analytics, informatics and information services include the following:
Pharma Analytics - Pharmaceutical Transactional Data and Market Analytics for pharmaceutical manufacturers, pharmacy benefit managers and other companies in the Pharma value chain;
Insurer Analytics - Hierarchical Condition Category (HCC) Analytics for healthcare insurers that reflect the impacts of CMS Risk Adjustment Factors (RAFs);
Phase IV Analytics - Phase IV Observational Epidemiologic Studies for pharmaceutical manufacturers; and
Price & Performance Analytics - Price indexes and analytics for healthcare products and services in order to assist their suppliers in complying with requirements of the Healthcare Price Transparency Act of 2012.
Our services are supported by a rich portfolio of Health Information Technology solutions that have been secured thru strategic alliances or will be internally developed and patented.
bottom of page